Inflammatory Bowel Diseases

Journal

Publication Venue For

  • Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data from the IBM MarketScan® Administrative Claims Database with Tofacitinib Trial Data.  27:1394-1408. 2021
  • Challenges in IBD Research: Pragmatic Clinical Research.  25:S40-S47. 2019
  • Challenges in IBD Research: Preclinical Human IBD Mechanisms.  25:S5-S12. 2019
  • Improved Quality of Life with Anti-TNF Therapy Compared with Continued Corticosteroid Utilization in Crohn's Disease.  25:925-936. 2019
  • Abdominal pain and the neurotrophic system in ulcerative colitis.  20:2330-2339. 2014
  • Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models.  20:363-377. 2014
  • Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.  19:2744-2752. 2013
  • Linking vitamin D deficiency to inflammatory bowel disease.  19:2245-2256. 2013
  • Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis..  19:1339-1345. 2013
  • HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and TH1/TH17 responses.  19:151-164. 2013
  • Independent replication of an association of CNVR7113.6 with Crohn's disease in caucasians.  18:305-311. 2012
  • Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis.  18:236-245. 2012
  • Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis.  17:2287-2294. 2011
  • Impact of capsule endoscopy on management of inflammatory bowel disease: A single tertiary care center experience.  17:1855-1862. 2011
  • Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease.  17. 2011
  • Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations.  16:2080-2089. 2010
  • Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults.  15:684-696. 2009
  • Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.  14:1641-1651. 2008
  • Therapeutic benefit of pentostatin in severe IL-10-/- colitis..  14:880-887. 2008
  • III. Report of adaptive and regulatory immune responses workgroup.  14:694-696. 2008
  • X. Challenges update workgroups.  14:706-708. 2008
  • Isolation of flagellated bacteria implicated in Crohn's disease.  13:1191-1201. 2007
  • Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.  13:524-530. 2007
  • CCFA microbial-host interactions workshop: Highlights and key observations.  13:600-619. 2007
  • CCFA host-microbial interactions workshop: highlights and key observations.  13:600-19. 2007
  • Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice..  11:799-805. 2005
  • Gene disruption and immunity in experimental colitis.  10. 2004
  • Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs.  10:1-14. 2004
  • Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays..  10:1-14. 2004
  • Challenges in IBD research: Updating the scientific agendas.  9:137-153. 2003
  • Heritable susceptibility for colitis in mice induced by IL-10 deficiency.  6:290-302. 2000
  • Controversies in pediatric inflammatory bowel disease.  4:203-227. 1998
  • Why doesn't cyclosporine work in Crohn's disease?.  2:311-312. 1996
  • The effect of immunosuppressive agents on monocyte generation and cytokine expression.  1:266-275. 1995

    • International Standard Serial Number (issn)

  • 1078-0998

    • Electronic International Standard Serial Number (eissn)

  • 1536-4844